Industryweek 5869 Sanofi Promo

China Opens Investigation into Sanofi Bribery Claims

Aug. 12, 2013
China's top economic planner is currently investigating 60 foreign and domestic pharmaceutical companies over their prices.

BEIJING -- Beijing city health and corruption officials have launched an investigation into allegations staff at French pharmaceutical giant Sanofi (IW 1000/89) bribed more than 500 Chinese doctors a total of about $280,000, state media reported Saturday.

The joint investigation will probe claims in China's 21st Century Business Herald newspaper purporting to show that company staff paid 503 doctors in 79 hospitals bribes totaling 1.69 million yuan (US$276,000) in a bid to increase sales.

The paper, citing documents provided by an anonymous whistleblower, said Thursday that in 2007 Sanofi paid doctors 80 yuan (US$13) every time a patient bought its products, with the largest payment being 11,200 yuan.

Most of the payments were made to medical staff in hospitals in Beijing, the commercial hub of Shanghai, the southern city of Guangzhou and the eastern city of Hangzhou, and were listed as "research expenses," the report claimed.

The Beijing municipal health bureau will coordinate with the disciplinary authorities to investigate the case, a spokesman told state news agency Xinhua, it reported Saturday.

Sanofi said Thursday that it took the allegations "very seriously."

"We have zero tolerance to any unethical practice," the company said.

"Sanofi has established processes in place for reviewing and addressing such issues in a manner that is consistent with our legal and ethical obligations."

The allegations come after four executives from British drug firm GlaxoSmithKline (GSK) were arrested last month for alleged bribery and other offences.

China's top economic planner is currently investigating 60 foreign and domestic pharmaceutical companies over their prices.

Copyright Agence France-Presse, 2013

Popular Sponsored Recommendations

Onsite Wind Generation Guide for C&I

Jan. 22, 2024
This document offers insights into using onsite wind power for businesses, covering feasibility, project development, technology selection, and benefits of renewable energy.

A Guide to Payment Fraud Detection

Dec. 18, 2023
This guide explains the basics you should know about payment fraud, along with three tangible steps you can take to help your organization better mitigate the risk of payment ...

Service Lifecycle Management – Challenges and Opportunities

Feb. 18, 2024
Gain insights into the next wave of aftermarket optimization with Harvard Business Review’s whitepaper, in association with Tavant. Get an in-depth look at AI-powered Service ...

Decarbonizing Your Supply Chain: Striving for Net Zero

Feb. 12, 2024
Manufacturers face mounting pressure to decarbonize operations and supply chains. Meeting regulatory goals demands bold action and transparency. Collaboration with suppliers offers...

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!